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Corticotrophin-releasing factor (CRF) plays a key role in initiating many of the
endocrine, autonomic, and behavioral responses to stress. CRF-containing neurons
of the paraventricular nucleus of the hypothalamus (PVN) are classically involved in
regulating endocrine function through activation of the stress axis. However, CRF is
also thought to play a critical role in mediating anxiety-like responses to environmental
stressors, and dysfunction of the CRF system in extra-hypothalamic brain regions, like
the bed nucleus of stria terminalis (BNST), has been linked to the etiology of many
psychiatric disorders including anxiety and depression. Thus, although CRF neurons of
the PVN and BNST share a common neuropeptide phenotype, they may represent two
functionally diverse neuronal populations. Here, we employed dual-immunofluorescence,
single-cell RT-PCR, and electrophysiological techniques to further examine this question
and report that CRF neurons of the PVN and BNST are fundamentally different such
that PVN CRF neurons are glutamatergic, whereas BNST CRF neurons are GABAergic.
Moreover, these two neuronal populations can be further distinguished based on their
electrophysiological properties, their co-expression of peptide neurotransmitters such as
oxytocin and arginine-vasopressin, and their cognate receptors. Our results suggest that
CRF neurons in the PVN and the BNST would not only differ in their response to local
neurotransmitter release, but also in their action on downstream target structures.
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INTRODUCTION
Corticotrophin releasing factor (CRF) is a neuropeptide that is
essential for coordinating the adaptive response of an organ-
ism to stressful situations (Vale et al., 1981). CRF is produced
predominantly by neurons in the parvocellular division of the
paraventricular nucleus of the hypothalamus (PVN) (Swanson
et al., 1983; Herman et al., 2003). However, CRF is also pro-
duced by neurons in extra-hypothalamic limbic structures like the
extended amygdala, which includes the bed nucleus of the stria
terminalis (BNST) and the central nucleus of the amygdala (CeA),
as well as in hindbrain structures like the locus coeruleus and dor-
sal Raphé nuclei (Cummings et al., 1983; Curtis and Valentino,
1994; Snyder et al., 2012). CRF that is synthesized and released
by PVN neurons plays a major role in regulating activity of the
hypothalamic-pituitary-adrenal (HPA) axis and triggers the clas-
sic endocrine stress response (Vale et al., 1981; Rivier and Vale,
1983), whereas outside the HPA axis CRF acts not as a hormone,
but as a modulator of synaptic transmission at pre- and postsy-
naptic sites within specific central neuronal circuits (Lowry and
Moore, 2006; Orozco-Cabal et al., 2006). In the BNST, the highest
concentration of CRF neurons are found in the oval and fusiform
nuclei (Cummings et al., 1983; Morin et al., 1999), which is also
rich in CRF fibers and terminals, many of which originate from
the CeA (Cummings et al., 1983; Sakanaka et al., 1986; Morin
et al., 1999). Growing evidence suggests that CRF neurons of
the anterolateral cell group of the BNST, BNSTALG, play a major
role in the affective response to stressors (Lee and Davis, 1997;
Liang et al., 2001; Nijsen et al., 2001; Ciccocioppo et al., 2003;
Sahuque et al., 2006; Dabrowska et al., 2013), and that dysfunc-
tion of this CRF system contributes to the etiology of several
psychiatric disorders, including depression (Crestani et al., 2010),
anxiety-disorders (Walker et al., 2009), as well as addiction (Koob,
2010).
However, despite sharing a common neuropeptide phenotype,
central CRF neurons should not be regarded as a homogeneous
cell population. For example, the Raphé nuclei contain a popula-
tion of CRF neurons that co-localize serotonin (5-HT) (Valentino
et al., 2010), whereas locus coeruleus CRF neurons co-localize
noradrenalin (NA) (Valentino et al., 1983, 2010). Hence, tar-
get structures that receive input from CRF neurons in these two
midbrain nuclei would be predicted to have a markedly dif-
ferent response to afferent input. Consistent with this premise,
evidence from in situ hybridization and immunohistochemical
studies suggest that PVNCRF neurons could have a glutamatergic
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phenotype (Ziegler et al., 2002; Lin et al., 2003; Hrabovszky et al.,
2005; Hrabovszky and Liposits, 2008), whereas BNST CRF neu-
rons could be GABAergic (Sun and Cassell, 1993; Bowers et al.,
1998; Day et al., 1999; Pompolo et al., 2002). This raises the
intriguing possibility that either CRF neurons in these two stress-
reactive structures have a phenotype that is independent of the
surrounding structure or that they co-express two functionally
opposing neurotransmitters. Support for the latter premise comes
from the observation that stress responsive neurons in the BNST,
but not the PVN, are primarily GABAergic (Herman et al., 1996;
Day et al., 1999; Bali et al., 2005; Janitzky et al., 2009). However,
no study to date has systematically examined the neurochemical
phenotype of CRF neurons in these two regions at the single cell
level.
As noted above, the PVN and BNST also contain subpopu-
lations of neurons that express a wide variety of neuropeptides
including, but not limited to, oxytocin (OT), arginine-vasopressin
(AVP), neurotensin (NT), and enkephalin (ENK) (Sawchenko
et al., 1984a,b; Lightman, 1993), some of which are co-expressed
in the same cell populations. For example, although AVP is pri-
marily produced by magnocellular PVN neurons, under stress
conditions parvocellular CRF neurons in the PVN also co-
synthesize AVP (Sawchenko et al., 1984a; Arima et al., 2001), sug-
gesting that the neurochemical phenotype of these neurons can
be dynamically regulated in response to environmental demands.
Interestingly, CRF and OT are also reported to be co-expressed
in a subset of PVN neurons (Sawchenko et al., 1984b), and our
recent single-cell RT-PCR study confirmed that some magnocel-
lular OT neurons in the PVN also co-express mRNA transcripts
for CRF (Dabrowska et al., 2011). Together these data suggest
that stress responsive CRF neurons may have a phenotype that
is both region-specific and dynamically regulated in response to
environmental stimuli.
Finally, we recently reported that a reciprocal relationship
exists between CRF neurons of the BNSTALG and OT neurons
of the PVN (Dabrowska et al., 2011). Hence, magnocellular OT
neurons in the PVN express high levels of type 2 CRF recep-
tors (CRFR2), whereas BNSTALG CRF neurons express high levels
of OT receptor mRNA (OTR), suggesting that OT neurons of
the PVN might directly regulate the excitability of the CRF neu-
rons in the BNSTALG and vice versa. However, OT is also released
locally in the PVN (Neumann, 2007), raising the possibility that
CRF neurons in the PVN may also be regulated by local OT
release. Indeed, we have shown that magnocellular CRF neu-
rons in the PVN express OTR mRNA (Dabrowska et al., 2011),
however, nothing is known about OTR expression in the par-
vocellular CRF cell population. Furthermore, although multiple
neuronal subtypes have been characterized in the rat PVN (Tasker
and Dudek, 1991) and BNST (Hammack et al., 2007; Hazra
et al., 2011) based on their electrophysiological properties, lit-
tle is known about the properties of CRF expressing neurons
due to the lack of a cell-type specific marker for these neurons.
To address these knowledge gaps, we have used a combination
of dual-immunofluorescence and whole-cell patch clamp record-
ing in conjunction with single-cell RT-PCR to probe rat CRF
neurons in both regions for their expression of GABAergic (glu-
tamic acid decarboxylase, GAD67) and glutamatergic (vesicular
glutamate transporter, VGLUT) markers, as well as for other neu-
ropeptides (OT, AVP) and their cognate receptors (OTR, V1AR,
V1BR).
METHODS
ANIMAL SUBJECTS
All experiments were performed on brain tissue obtained from
adult (60 days old), male, Sprague-Dawley rats (Charles River
Laboratories, Wilmington, MA). Animals were housed 4 ani-
mals per cage and were maintained on a 12:12-h light–dark
cycle with ad libitum access to food and water. For experiments
that required stereotaxic surgery and colchicine injections, rats
were anaesthetized with an IP injection of a mixture of dexdor-
mitor (0.16mg/kg; Pfizer Animal Health, New York, NY, USA)
and ketamine hydrochloride (48mg/kg; Butler-Schein Animal
Health, Dublin, OH, USA). All procedures used were approved
by the Institutional Animal Care and Use Committees (IACUC)
of Emory University, and were in compliance with National
Institutes of Health (NIH) guidelines for the care and use of
laboratory animals.
TISSUE PROCESSING FOR IMMUNOFLUORESCENCE
To facilitate immunohistochemical analysis, 6 rats received a 2μl
intracerebroventricular (icv) colchicine (Sigma Aldrich, St. Louis,
MO, USA, 60μg/μl) infusion 48 h prior to transcardial perfu-
sion to maximize CRF peptide content in neuronal cell bodies,
as described previously (Dabrowska et al., 2011). Subsequently,
all rats were transcardially perfused with 4% paraformaldehyde
and subsequent fixation procedure was performed as described
elsewhere (Dabrowska and Rainnie, 2010).
DUAL-IMMUNOFLUORESCENCE EXPERIMENTS
The specificity of the antibodies used in this study has been con-
firmed and described previously (Martin et al., 2010; Dabrowska
et al., 2011). Dual-immunofluorescence experiments were per-
formed using the following primary antibodies: rabbit polyclonal
anti-CRF antibody (1:250, ab11133, Abcam, Cambridge, MA),
mouse monoclonal anti-GAD67 (1:500, MAB5406, Chemicon-
Millipore, Billerica, MA), mouse monoclonal anti-VGLUT2 anti-
body (1:1000, clone N29/29, 75-067, UC Davis/NIH NeuroMab
Facility, Davis, CA, USA, Antibodies Incorporated) and using
protocols that have been described previously (Dabrowska et al.,
2011).
To examine the co-localization of CRF with GAD67 and
VGLUT2, we performed dual-immunofluorescence experiments
on free-floating serial sections of the rat BNSTALG and PVN
as described before (Dabrowska et al., 2011). Here, representa-
tive sections were taken from Bregma +0.22 to −0.4mm for the
BNSTALG, and from −1.6 to −2.12mm for PVN. The sections
were rinsed 3× (10min each) in phosphate buffer saline (PBS),
permeabilized with 0.5% Triton-X 100 in PBS, and incubated for
48 h at 4◦C with the following primary antibodies pairs diluted
in 0.5% Triton-X/PBS solution: CRF/GAD67 and CRF/VGLUT2.
Sections were rinsed 3× (10min each) in PBS and then incubated
at room temperature for 2 h with Alexa-Fluor secondary antibod-
ies specific for the primary antibody host: namely Alexa-Fluor
488 goat anti-mouse IgG and Alexa-Fluor 568 goat anti-rabbit
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IgG (1:500, Invitrogen, Carlsbad, CA, USA). Following incuba-
tion with secondary antibodies, sections were rinsed 3× in PBS
and 1× in 0.05M phosphate buffer (PB), mounted on gelatin-
coated glass slides and coverslipped using mounting medium
consisting of 12% mowiol (Sigma Aldrich, St. Louis, MO, USA)
and 30% glycerol. Confocal spinning disk laser microscopy was
used to analyze dual-immunofluorescence patterns and to obtain
high-resolution photomicrographs using an Orca R2 cooled CCD
camera (Hamamatsu, Bridgewater, NJ, USA) mounted on a Leica
DM5500B microscope (Leica Mircosystems, Bannockburn, IL)
equipped with a CSU10B Spinning Disk (Yokagawa Electronic
Corporation, Tokyo, Japan). Analysis and semi-quantitative anal-
ysis of dual-labeled neurons in the PVN and the BNSTALG
was performed with Simple PCI 6.6 software (Hamamatsu
Corporation, Sewickley, PA, USA). For each pair of primary
antibodies, immunoreactive neurons from representative sections
containing either the BNSTALG, or the PVN, (from three animals,
thirty sections total) were counted and analyzed for dual-labeling.
Co-localization was determined by capturing confocal Z-stack
images and counting the number of neurons co-localizing the two
markers (VGLUT2/CRF or GAD67/CRF) in all focal plans. Cell
counts were then expressed as a percentage of the total number of
neurons expressing CRF.
SINGLE-CELL RT-PCR
Single cell RT-PCR (scRT-PCR) protocols and the procedures
used to determine mRNA transcript expression in single cells
of the PVN and BNSTALG have been described in detail else-
where (Dabrowska et al., 2011; Hazra et al., 2011). Briefly,
following recording of the electrophysiological properties of neu-
rons in each area, the cytoplasm was aspirated from recorded
neurons into the patch recording pipette and then expelled
into a microcentrifuge tube containing a reverse transcription
(RT) cocktail (Applied Biosystems, Foster City, California). The
RT product was then amplified in triplicate and screened for
18S rRNA expression. Only those cells positive for 18S rRNA
were subjected to amplification with primers. Oligonucleotide
primers used in the current study have been described else-
where (Dabrowska et al., 2011; Hazra et al., 2011), with
the exception of V1AR and V1BR, as well as VGLUT1 and
VGLUT3. The primers used for V1 receptors were as follows:
5′-CGACACAGCAAGGGTGACAAGG-3′ and 5′-AGGAAGCCA
G CAACGCCG-3′ (accession number NM_053019.2, 265 bp)
for V1AR, and 5′-AGCATCAGTACCATCTCCAGG-3′ and 5′-
TGGTCTCCATAGTGGCTTCC-3′ (NM_017205.2, 463 bp) for
V1BR. The primers used for VGLUT were as follows: 5′-ACCC
ATCGGAGGCCAGATCG-3′ and 5′-GCCACTCCTCCCGC GT
CTTGTGC-3′ (NM_053859, 416 bp) for VGLUT1 and 5′-GGAA
TCATTGACC AAGATGAGTTAGCTGA-3′and 5′-TTT AGGT
GTTTCTGAGAAGT CTCCTTCGG-3′ (AY117026, 200 bp) for
VGLUT3.
CONTROLS FOR THE scRT-PCR
PCR conditions were optimized using total RNA isolated from
rat BNSTALG so that a PCR product could be detected from
(250 pg − 1 ng) of total RNA without contamination caused by
non-specific amplification. For each PCR amplification, sterile
water was used instead of cDNA as a control for contaminating
artifacts. A second negative control was performed in which the
RT enzyme was excluded from the initial reaction mixture for
each amplification reaction. All of the control tests gave nega-
tive results throughout the study. In addition, all of the primers
used in this study were intron-spanning to exclude amplification
of genomic DNA. Moreover, the cell nucleus was never har-
vested while isolating mRNA from single cells further reducing
the possibility of contamination by genomic DNA.
IN VITROWHOLE CELL PATCH-CLAMP RECORDING OF VISUALLY
IDENTIFIED NEURONS IN THE PVN AND THE BNSTALG
In vitro patch-clamp recordings were performed as previously
described (Guo and Rainnie, 2010; Hazra et al., 2011). In brief,
rat were anesthetized using isoflurane and the brains rapidly
removed and placed into ice-cold kynurenic-based artificial cere-
brospinal fluid (ACSFKA), which contained (in mM): NaCl (130),
KCl (3.5), KH2PO4 (1.1), MgCl2 (6.0), CaCl2 (1.0), NaHCO3
(30), glucose (10), and kynurenic acid (2). Subsequently, 350μm
slices containing the BNSTALG or PVN were obtained using
a Leica VTS-1000 vibrating microtome (Leica Microsystems,
Bannockburn, IL). ACSFKA was used to minimize any potential
excitotoxicity associated with glutamate release during tissue slic-
ing. Immediately after slicing, slices were hemisected, trimmed,
and placed in a holding chamber containing oxygenated ACSFKA
at room temperature for 1 h. Slices were then transferred to oxy-
genated regular ACSF containing (in mM): NaCl (130), NaHCO3
(30), KCl (3.50), KH2PO4 (1.10), MgCl2 (1.30), CaCl2 (2.50),
and glucose (10). Slices were kept in the regular ACSF at room
temperature for at least 30min before recording. For recording,
individual slices were transferred to a Warner Series 20 recording
chamber (0.5ml volume) mounted on the fixed stage of a Leica
DM-LFS microscope (Leica Microsystems). The slices were main-
tained fully submerged and continuously perfused with ACSF
heated to 32◦C, and gassed with a 95–5% oxygen/carbon dioxide
mixture. Neurons were visually identified using differential inter-
ference contrast (DIC) optics, infrared (IR) illumination, and an
IR sensitive CCD camera (Orca ER, Hamamatsu, Tokyo Japan).
Standard whole-cell recordings in current- and voltage-clamp
mode were obtained from BNSTALG and PVN neurons using a
MultiClamp 700B amplifier (Molecular Devices, Sunnyvale, CA),
with a Digidata 1320A A-D interface, and pClamp 10 software
(Molecular Devices). Current-clamp signals were filtered at 5 kHz
and digitized at 10–20KHz. Patch pipettes were fabricated from
borosilicate glass (resistance 4–7M) and filled with a recording
solution of the following composition (in mM): 130 K-gluconate,
2 KCl, 10 HEPES, 3MgCl2, and 5 phosphocreatine, 2 K-ATP, 0.2
NaGTP.
For all experiments, whole-cell patch-clamp configuration was
established only when the seal resistance was >1.5 G. Neurons
were excluded from analysis if they showed a resting mem-
brane potential (Vm) more positive than −50mV and/or had
an action potential that did not overshoot +10mV. Series resis-
tance (Rs) was bridge balanced and neurons with Rs > 25M
were not included in analysis. Standardized protocols were used
to determine the membrane properties of PVN and BNST neu-
rons as previously described (Hammack et al., 2007). Briefly,
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the voltage response of neurons was determined using transient
(750ms) outward and inward current steps of 10–50 pA based
on membrane input resistance (Rm) of neurons, with the max-
imum hyperpolarizing voltage deflection restricted to ∼ −90mV.
Action potential properties were determined using an inward
ramp of current (250ms) sufficient to drive a single action poten-
tial. All electrophysiological data were analyzed with a custom
made MATLAB 2009a script (Mathwork, Natick, MA). In a sub-
population of PVN neurons, 0.3% biocytin was included in the
patch recording solution for morphological reconstructions as
previously described (Hazra et al., 2011). PVNpc and PVNmc
cells were distinguished from one another based on their relative
medial / lateral location in the PVN, as well as by the apparent
size of their soma (PVNpc = 10.7 ± 0.5μm, n = 18; PVNmc =
18.8 ± 0.8μm, n = 18).
STATISTICAL ANALYSIS
Statistical analyses were carried out using Prism 4 (GraphPad, La
Jolla, CA). Tests for significant effect of cell type were performed
using one way analysis of variance (ANOVA). To perform pair-
wise comparisons following significant main effects in ANOVA,
Bonferroni multiple comparisons test were used. A t-test was
used when only two cell types (PVNpc and PVNmc) were being
compared. For all tests, significance was defined at α = 0.05.
RESULTS
DUAL-IMMUNOFLUORESCENCE
GAD67 and VGLUT2 expression in the PVN
To determine the predominant amino-acid neurotransmitter
phenotype of CRF neurons in the PVN and BNSTALG, we per-
formed dual-immunofluorescence for CRF together with specific
markers for glutamatergic and GABAergic neurons. We chose
GAD67 as the marker of GABAergic neurons because previous
studies had shown a high levels of GAD67 mRNA expression in
the BNST (Pompolo et al., 2002). Similarly, although three dif-
ferent isoforms of VGLUT are found in the CNS (Ziegler et al.,
2002; Herzog et al., 2004), VGLUT2 is the predominant glutamate
transporter found in the PVN (Hrabovszky et al., 2005). Hence,
we conducted dual-immunofluorescence studies to examine the
relative degree of co-expression of CRF with GAD67 or VGLUT2
in the PVN and the BNSTALG.
As expected, CRF-immunoreactivity in the PVN was mainly
localized in a subpopulation of parvocellular neurons in the
medial parvocellular division and, to a lesser extent, in a sub-
population of magnocellular neurons (Figures 1A–C). In con-
trast, GAD67-immunoreactivity showed high somatodendritic
expression in the perinuclear division of the PVN and low
expression in either the parvocellular or magnocellular sub-
divisions (Figure 1B’). Dual-immunofluorescence experiments
demonstrated that CRF- and GAD67-immunoreactive neurons
exist mainly in adjacent, but mutually exclusive, neuronal sub-
populations in the hypothalamus, and only 13% (16/124) of
CRF neurons in the PVN co-localize GAD67 (Figure 1B”).
Conversely, VGLUT2-immunoreactivity showed high somato-
dendritic labeling throughout the PVN (Figure 1C’) and our
dual-immunofluorescence experiments revealed that the great
majority (82%, 67/82) of CRF-positive neurons in the PVN
also co-localized VGLUT2 (Figure 1C”). However, numerous
VGLUT2 positive neurons were also observed in the PVN that did
not co-localize CRF.
GAD67 and VGLUT2 expression in the BNSTALG
In agreement with previous studies, CRF-immunoreactive neu-
rons were concentrated in the oval and fusiform nuclei of the
BNST, which also showed a dense network of CRF-positive
fibers (Figures 2A–C). Consistent with previous in situ studies
(Day et al., 1999; Pompolo et al., 2002), a high level of GAD67
somatodendritic immunoreactivity was observed throughout the
BNSTALG (Figure 2B’), and dual-immunofluorescence experi-
ments further revealed that 95% (61/64) of CRF-positive neurons
in the oval nucleus co-localized GAD67 (Figure 2B”). However,
the majority of GAD67-positive neurons in the BNSTALG do not
co-localize CRF. Unlike GAD67, VGLUT2 immunoreactivity in
the oval nucleus of the BNSTALG was low, and restricted mainly
to the neuropil where it presented asmore punctuate-like labeling
rather than the somatodendritic labeling of GAD67 (Figure 2C’).
Furthermore, unlike GAD67, a somatic co-expression of VGLUT2
in CRF-positive neurons of the BNSTALG was never observed
(Figure 2C”).
Having determined that CRF neurons of the oval nucleus of
the BNSTALG and PVN could be differentiated based on their
amino acid neurotransmitter phenotype, we were interested to
see if they could be further differentiated based on their relative
expression of other neuropeptides and their cognate receptors.
Technical constraints limit the number of epitopes that can be
labeled by antibodies in a single neuron and, hence, we next used
a combination of whole-cell patch-clamp recording and single-
cell RT-PCR to screen physiologically identified neurons in the
parvocellular and magnocellular divisions of the PVN (PVNpc
and PVNmc, respectively), and BNSTALG for their expression of
mRNA transcripts for multiple peptide neurotransmitters and
their receptors.
SINGLE-CELL RT-PCR
Having visually identified putative PVNmc and PVNpc neurons,
and BNSTALG neurons, we first recorded their basic electro-
physiological properties (see below) and then extracted cytosolic
mRNA (see Methods). Figures 3A–C shows representative pho-
tomicrographs of putative magnocellular and parvocellular neu-
rons in the PVN. In a subpopulation of neurons biocytin was
included in the recording pipette to allow subsequent morpho-
logical reconstruction of the PVN neurons. Typical examples
of a putative PVNmc (right) and PVNpc neuron (left) in the
medial dorsal PVN are shown in Figure 3D. The combined
results of our scRT-PCR analysis of mRNA transcripts obtain
from neurons in the two divisions of the PVN and BNSTALG are
summarized below and in Tables 1, 3. The physiological proper-
ties of BNSTALG and PVN neurons that express CRF transcripts
are described briefly in the following section, and summarized
in Table 2.
Expression of mRNA transcripts in PVN neurons
Single-cell RT-PCR analysis was performed on mRNA isolated
from 43 PVN neurons, of which 21 were putative PVNpc
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FIGURE 1 | (A) Photomicrograph showing high somatodendritic
immunoreactivity of CRF in the parvocellular neurons of the PVN
(magnification 10×, scale bar 10μ, 3rd V- third ventricle). (B–B”):
Photomicrographs showing non-overlapping somatodendritic
immunoreactivity of CRF (B, red, closed arrows) and GAD67 (B’, green, open
arrows) in the PVN (B”,merged). Occasionally, CRF-positive cells demonstrate
immunolabeling for GAD67 as indicated by double arrow. (C–C”) In contrast,
CRF-immunoreactive neurons (B, red) are highly co-localized with
VGLUT2-positive neurons (B’, green) in the parvocellular PVN (merged arrows,
magnification 63×, scale bar 10μm).
neurons, and 22 were putative PVNmc neurons. Previously,
we have briefly described the genetic phenotype of a sam-
ple population of magnocellular PVN neurons (Dabrowska
et al., 2011). Here, we extend these studies to include a more
detailed examination of the phenotype of PVNpc and PVNmc
neurons.
To verify the results from our immunohistochemical studies,
all neurons were initially screened for the presence of mRNA tran-
scripts for GAD67, as well as VGLUT1, VGLUT2, and VGLUT3.
As expected, 86% (37/43 neurons) of PVN neurons screened in
this study expressed mRNA transcripts for VGLUT2, and none
expressed GAD67 transcripts, further confirming that PVN neu-
rons have a predominantly glutamatergic phenotype. Moreover,
consistent with results from previous in situ hybridization stud-
ies (Ziegler et al., 2002; Herzog et al., 2004; Singru et al., 2012),
none of the PVN neurons screened expressed mRNA transcripts
for either VGLUT1 or VGLUT3 (data not shown), suggesting
that VGLUT2 is a unique identifier for glutamatergic neurons of
the PVN. Having established that PVN neurons were predomi-
nantly glutamatergic we next examined the relative extent of co-
expression of CRF mRNA transcripts with VGLUT2 transcripts.
In 21 PVNpc neurons screened, 62% (13/21) expressed mRNA
transcripts for CRF. Consistent with our immunohistochemical
data, 92% (12/13) of PVNpc neurons that expressed CRF mRNA
transcripts also expressed VGLUT2, and none expressed GAD67
transcripts.
Next, we examined the relative extent of co-expression of
CRF transcripts in PVNpc neurons with transcripts for OT,
AVP, and ENK, together with the cognate receptors for OT
and AVP. As illustrated in Table 1, 77% of parvocellular CRF-
positive neurons (10/13) were seen to co-express mRNA tran-
scripts for OT and V1BR, 54% for CRFR2 (7/13), and only 8%
expressed transcripts for ENK (1/13). None of the parvocellu-
lar CRF neurons examined in this study expressed transcripts for
CRFR1, AVP, OTR, or V1AR mRNA. In contrast, 75% of non-
CRF parvocellular neurons expressed ENK and OTR (6/8), 62%
expressed VGLUT2 and CRFR2 (5/8), 37% expressed transcripts
for AVP (3/8), and only 25% expressed transcripts for OT and
V1BR (2/8).
We have previously briefly described the expression phe-
notype of a sample population of magnocellular CRF-positive
neurons (Dabrowska et al., 2011). Here we extend these obser-
vations and compare their expression phenotype with that of
parvocellular CRF neurons. Out of 22 PVNmc neurons screened
in this study, only four expressed the mRNA for CRF. Like
parvocellular CRF neurons, 75% of magnocellular CRF neu-
rons (3/4) expressed mRNA transcripts for OT, CRFR2, and
V1BR, 50% expressed transcripts for VGLUT2 (2/4), and 25%
expressed transcripts for AVP and ENK (1/4). Interestingly,
whereas no parvocellular CRF neurons expressed transcripts for
OTR, 50% of magnocellular CRF neurons showed OTR expres-
sion. Finally, V1BR transcripts were preferentially expressed
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FIGURE 2 | (A) Photomicrograph showing high somatodendritic
immunoreactivity of CRF in the BNSTALG (magnification 10×, scale bar 100μ,
ac, anterior commissure; cp, caudate putamen; BNSTov, oval nucleus of the
BNST; BNSTju, juxtacapsular nucleus of the BNST). (B–B”): Photomicrographs
showing high-level co-localization of CRF (B, red) and GAD67 (B’, green) in the
BNSTALG (B”, merged, double arrows). Virtually all CRF-immunoreactive
neurons co-express GAD67, but numerous GAD67-positive neurons do not
co-localize CRF in the BNSTALG. (C–C”) In contrast, CRF-immunoreactive
neurons (B, red, open arrows) do not co-localize VGLUT2 (C’, green) in the
BNSTALG (magnification 63×, scale bar 10μm).
FIGURE 3 | Localization of parvocellular and magnocellular neurons in
the PVN. (A) A schematic diagram showing the recording sites from the
PVN neurons. (B,C) Representative images showing the cytoarchitecture of
magnocellular and parvocellular neurons under DIC illumination. (D)
Immunofluoroscence image showing two anatomically reconstructed PVN
neurons, one parvocellular and one magnocellular. Scale bar 25μm.
by CRF neurons and were never observed to co-express with
AVP mRNA transcripts in either PVNpc or PVNmc, suggest-
ing that V1BR does not serve as an autoreceptor in AVP
neurons.
Expression of mRNA transcripts in BNSTALG neurons
Previously, we have shown that three physiologically and geneti-
cally distinct subclasses of neurons are present in the BNSTALG,
Type I–III (Hammack et al., 2007; Hazra et al., 2011). Type III
BNSTALG neurons are putative CRF neurons, since the major-
ity (95%) of these neurons express mRNA transcripts for CRF,
and display a unique ion channel expression pattern that corre-
lates with their electrophysiological features (Hazra et al., 2011).
To determine if CRF neurons of the BNSTALG share a phenotype
with parvocellular CRF neurons of the PVN we screened Type
I–III BNST neurons for the presence of GAD67 and VGLUT1-3
transcripts. Significantly, all BNSTALG neurons tested, irrespec-
tive of cell type, expressed GAD67 mRNA transcripts, but none
of these neurons expressed transcripts for VGLUT1-3. These
findings confirmed our immunohistochemical observations that
CRF neurons in the BNSTALG have a predominantly GABAergic
phenotype.
Having established that CRF neurons of the PVN and
BNSTALG could be differentiated based on their amino-acid phe-
notype, we next examined whether additional differences could
be found in their peptidergic phenotype. The results of this
study are summarized in Table 1. Significantly, unlike parvo-
cellular CRF neurons that showed 83% co-expression with OT
mRNA transcripts, none of the Type III CRF neurons tested
co-expressed OT. Conversely, whereas 95% of Type III neurons
expressed transcripts for OTR (18/19), no parvocellular CRF
neurons expressed OTR transcripts. Moreover, although 54%
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Table 1 | Transcriptomic analysis of CRF, non-CRF PVN cells, and Type I–III BNSTALG neurons.
Neurons CRF CRFR1 CRFR2 OT OTR AVP V1AR V1BR ENK VGLUT2 GAD67
PVNpc (21)
CRF 13 13 0 7 10 0 0 0 10 1 12 0
Non-CRF 8 0 0 5 2 6 3 0 3 6 5 0
PVNmc (22)
CRF 4 4 0 3 3 2 1 0 3 1 2 0
Non-CRF 18 0 1 15 17 3 2 0 4 10 18 0
Type I BNSTALG (20)
CRF 3 3 0 0 0 0 0 1 0 1 0 3
Non-CRF 17 0 4 0 0 0 0 16 1 1 0 17
Type II BNSTALG (20)
CRF 7 7 1 0 2 2 0 0 4 1 0 7
Non-CRF 13 0 1 1 1 6 0 0 7 9 0 13
Type III BNSTALG (20)
CRF 19 19 0 0 0 18 0 0 2 4 0 19
Non-CRF 1 0 1 1 0 1 0 0 1 1 0 1
Table 2 | Distinct membrane properties of CRF neurons in the PVN and BNSTALG.
CRF neurons RMP (mV) 1st ISI Rin (m) Spike
(ms)
Amplitude Half width Threshold Rise time Decay time fAHP
(mV) (ms) (mV) (ms) (ms) (mV)
PVNpc (12) −56.3 ± 0.94 24.1 ± 3.2 1180± 102 70.1 ± 2.4 1.003 ± 0.072 −33.1 ± 0.89 0.36 ± 0.022 0.98 ± 0.094 −14.5 ± 0.9
PVNmc (4) −55.2 ± 0.63 19.0 ± 3.3 373 ± 114** 73.3 ± 4.5 1.01 ± 0.042 −33.2 ± 1.12 0.37 ± 0.024 0.89 ± 0.030 −19.2 ± 2.6*
Type III −66.4 ± 0.97**,## 26.6 ± 4.5 226 ± 17** 76.9 ± 1.4 1.04 ± 0.024 −39.0 ± 0.75*,# 0.44 ± 0.016 1.12± 0.045 −4.9 ± 0.5**,##
BNST (19)
*,** p < 0.05 and 0.01 respectively, vs. PVNpc; #,##p < 0.05 and 0.01 respectively, vs. PVNmc. ISI, inter-spike-interval; PVNpc, parvocellular neurons of the PVN;
PVNmc, magnocellular neurons of the PVN.
of parvocellular CRF neurons expressed CRFR2 transcripts, no
expression was observed in Type III CRF neurons and, finally only
10% of Type III CRF neurons expressed V1BR transcripts (2/19),
whereas 77% of the parvocellular CRF neurons did. Hence, CRF
neurons in the BNSTALG and the PVNpc would be expected to
respond in distinctly different ways to local release of peptide
neurotransmitters.
Examination of mRNA transcript expression for the differ-
ent peptides and their receptors in Type I and Type II BNSTALG
neurons revealed that like CRF neurons, Type II BNSTALG neu-
rons never express V1AR transcripts, whereas 94% of non-CRF
Type I BNST neurons do. Interestingly, 36% of those Type II neu-
rons that co-expressed V1BR also expressed transcripts for CRF,
similar to Type III neurons.
ELECTROPHYSIOLOGICAL PROPERTIES OF PUTATIVE CRF NEURONS IN
THE PVN AND BNSTALG
Having determined that CRF neurons of the PVN and BNSTALG
have significantly different neurochemical phenotypes, we then
examined whether the electrophysiological properties of these
neurons was also different. The typical voltage response of CRF
neurons in the PVNpc, PVNmc, and BNSTALG to transient
(750ms) depolarizing and hyperpolarizing current injection is
illustrated in Figure 4. As can be seen in Figures 4A,B (left upper
traces), CRF neurons from both PVN regions displayed a sim-
ilar voltage response to transient current injection. Hence, all
neurons recorded from each region showed a moderate level
of spike-frequency adaptation in response to 750ms depolariz-
ing current injections (PVNpc n = 12, PVNmc n = 4). In con-
trast, BNSTALG CRF neurons exhibited a mixed firing pattern in
response to depolarizing current injection. Like CRF neurons in
the PVN, 11/19 BNSTALG CRF neurons showed spike-frequency
adaptation in the first 175 ± 20ms, and then settled down to
a regular firing pattern for the remainder of the pulse. The
remaining 8/19 neurons showed no spike-frequency adaptation
and fired regularly throughout the current injection protocol
(Figure 4C). In response to hyperpolarizing current injection,
voltage transients of neurons in each region showed a marked
time-independent anomalous rectification. However, on closer
examination one-way ANOVA tests found significant differences
in resting membrane potential [RMP, F(2, 32) = 31.7, p < 0.001],
input resistance [Rin, F(2, 32) = 76, p < 0.001], spike thresh-
old [F(2, 32) = 13.7, p < 0.001], and fast afterhyperpolarization
[fAHP, F(2, 32) = 31.7, p < 0.001], as summarized in Table 2.
Post-hoc Bonferroni tests revealed that parvocellular CRF neurons
had a significantly higher mean Rin than both the magnocellular
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FIGURE 4 | Distinct membrane properties of putative CRF neurons in
the PVN and type III CRF neurons in the BNSTALG. Representative
traces demonstrate the membrane responses of these neurons to
membrane current injections and typical spikes. (A) PVNpc neurons have
extremely high input resistance and high threshold for spike firing. When
hyperpolarized, these neurons exhibited an inward rectification current. No
outward rectification was observed during depolarization current injections.
Right trace shows a typical spike that has high firing threshold and a
prominent fAHP. (B) PVNmc neurons have smaller input resistance than
that of PNVpc neurons and also have high threshold for spike firing. Single
spike trace also shows this neuron has a high spike threshold and
prominent fAHP. (C) In comparison to the PVN CRF neurons, CRF neurons
in the BNST have lower input resistances, lower spike threshold and
smaller fAHP. PVNmc, PVNpc represent magnocellular and parvocellular
neurons of PVN respectively.
Table 3 | Comparison of mRNA transcript expression of IT current
channel subunits in PVN and BNSTALG CRF neurons.
CRF neurons Cav3.1 Cav3.2 Cav3.3
PVNpc (13) 10 6 0
PVNmc (4) 0 3 0
Type III BNST ALG (19) 0 0 16
CRF neurons, and BNST CRF neurons. On the other hand, both
the parvo- and magnocelluar CRF neurons in the PVN exhibited
a more pronounced fast after-hyperpolarizing potential (fAHP)
following each spike, as well as a more depolarized resting mem-
brane potential compared to that of BNSTALG CRF neurons.
Additionally, CRF neurons in the BNSTALG had a significantly
more hyperpolarized threshold for action potential than both
PVNpc and PVNmc neurons. The basic membrane properties of
putative CRF neurons in the PVN and BNSTALG are summarized
in Table 2.
Previous studies in the PVN had reported that expression of
the low-threshold calcium current, IT, was a unique identifier of
parvocellular PVN neurons, which was markedly attenuated, or
absent, in PVNmc neurons (Tasker and Dudek, 1991; Luther and
Tasker, 2000), and that expression of this current may underlie
differences in the firing patterns observed in these two regions.
Similarly, we have shown that the firing pattern of BNSTALG neu-
rons is dependent on and interplay between IT and the transient
outward potassium current, IA (Hammack et al., 2007). Hence,
activation of IT may play a significant role in regulating the fir-
ing activity in CRF neurons in both the PVN and the BNSTALG.
As illustrated in Figure 4, CRF neurons in both the PVNpc and
PVNmc failed to exhibit any of the rebound burst firing prop-
erties that were previously reported for type II neurons in the
PVNpc (Luther and Tasker, 2000). However, burst firing was
observed in a small population of non-CRF PVNpc neurons (data
not shown). Alternatively, we reasoned that IT activation may
influence the firing activity of PVNpc CRF neurons by regulat-
ing the inter-spike interval (ISI) between the first two spikes of
a train of action potentials. Indeed, when looking at all of the
PVNpc and PVNmc neurons, including those that do not express
CRF, PVNpc neurons displayed a tendency toward a shorter 1st
ISI in comparison to PVNmc neurons (26.8 ± 4.7 vs. 42.5 ±
11.2ms; p > 0.05), which may be indicative of more IT activa-
tion. However, no significant difference was observed for the 1st
ISI in CRF PVNpc and PVNmc neurons (24.1 ± 3.2 vs. 19.0 ±
3.3ms, respectively), suggesting that CRF neurons in these two
regions may share common properties that are distinct from non-
CRF neurons. Although CRF neurons of the PVN and BNSTALG
share many basic electrophysiological properties; Table 2 illus-
trates that BNSTALG CRF neurons can be differentiated from
their PVN counterparts in some of their basic membrane prop-
erties, which could significantly influence their response to
excitatory afferent inputs. These data are consistent with our
dual-immunofluorescence results, further suggesting that CRF
neurons in the PVN and BNST represent distinct neuronal
populations.
EXPRESSIONOF IT CHANNEL SUBUNITS IN CRF NEURONS OF THE
PVN AND BNSTALG
To determine if the differences observed in the 1st ISI may be
dependent on differential expression of IT channel subunits, we
next examined the relative expression ofmRNA transcripts for the
IT channel subunits Cav3.1, Cav3.2, and Cav3.3 in CRF neurons of
the PVN and BNSTALG. As illustrated in Table 3, 54% (7/13) of
CRF-positive neurons in the PVNpc expressed mRNA transcripts
for the Cav3.1 subunit, whereas only 38% (5/13) expressed tran-
scripts for the Cav3.2 subunit. In contrast, the only IT channel sub-
unit transcript expressed by PVNmc CRF neurons was the Cav3.2
subunit. Hence, 75% (3/4) of PVNmc CRF neurons co-expressed
Cav3.2 subunit transcripts. Significantly, the majority of non-CRF
PVNmc neurons (15/22) failed to show mRNA transcript expres-
sion for any of the IT channel subunits (data not shown). In con-
trast to CRF neurons in the PVN, 85% of Type III CRF neurons
in the BNSTALG expressed mRNA transcripts for the Cav3.3 sub-
unit, but did not express transcripts for either Cav3.1 or Cav3.2
subunits.
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DISCUSSION
In this study we have demonstrated that CRF neurons in the
PVNpc and in the BNSTALG display unique and regionally dis-
tinct expression patterns not only for the major amino acid
neurotransmitters glutamate and GABA, but also for other neu-
ropeptides and their receptors that are known to play a major
role in the behavioral response to stress. Hence, our dual-
immunofluorescence and scRT-PCR experiments revealed that
PVNpc CRF neurons are predominantly glutamatergic, have the
potential to synthesize and release oxytocin (OT), are unlikely
to respond to local OT release, but could respond to local AVP
and CRF release through activation of V1B and CRF2 recep-
tors, respectively. Notably, PVNmc CRF neurons have a similar
profile to that of PVNpc neurons. Conversely, Type III CRF
neurons in the BNSTALG are predominantly GABAergic, do not
have the ability to release OT or AVP, but could respond to
local OT and AVP release via activation of OT and V1B recep-
tors. Moreover, CRF neurons in the BNSTALG do not express
CRF2 receptors and, hence, local CRF release would be predicted
to differentially modulate the activity of CRF neurons in these
two regions. Finally, our physiological data further suggests that
excitatory afferents would be more likely to drive PVNpc CRF
neurons to fire action potentials than they would CRF neurons
of the BNSTALG, even though the action potential threshold is
lower in BNSTALG neurons, due to PVNpc neurons having a
more depolarized resting membrane potential and higher input
resistance.
Vesicular glutamate transporters are the main regulators of
glutamate uptake into synaptic vesicles prior to its release from
axon terminals (Fujiyama et al., 2001). To date three isoforms
have been identified, VGLUT1-3, each of which show differen-
tial expression in the CNS (Ziegler et al., 2002; Herzog et al.,
2004). Here we report that CRF neurons of the PVNpc and
PVNmc exclusively express mRNA transcripts for VGLUT2, but
not VGLUT1 or VGLUT3. The data is consistent with previous
in situ hybridization and immunocytochemical studies show-
ing that VGLUT2 is the predominant isoform expressed in the
PVN (Ziegler et al., 2002), and that hypophysiotropic parvo-
cellular CRF neurons of the PVN express VGLUT2 (Lin et al.,
2003; Hrabovszky et al., 2005). Similarly, VGLUT2 has been
reported to be the predominant glutamate transporter expressed
by almost all hypothalamic neuroendocrine neurons, including
CRF, thyrotropin releasing hormone (TRH; Herman et al., 2002;
Hrabovszky and Liposits, 2008), OT, and AVP expressing neu-
rons (Takamori et al., 2000; Herzog et al., 2001; Dabrowska et al.,
2011), suggesting that glutamatemay be the principal neurotrans-
mitter released by these neurons under basal firing conditions.
Unlike fast amino-acid synaptic transmission, release of pep-
tide neurotransmitters is slow, requiring high frequency firing to
elicit release, and is thought to modulate subsequent fast amino-
acid transmission (Kits and Mansvelder, 2000; Greengard, 2001).
Hence, transmission in efferent pathways from PVNCRF neurons
may switch from solely glutamate, to glutamate and CRF during
times of high PVN activation. Significantly, CRF has been shown
to facilitate glutamatergic transmission in multiple brain regions
(Liu et al., 2004; Rainnie et al., 2004; Hahn et al., 2009) but see
(Gallagher et al., 2008), suggesting that concurrent activation of
postsynaptic glutamate and CRF receptors may enhanceHPA axis
activity in response to chronic or intense stress stimuli.
Consistent with previous immunohistochemical studies
(Cullinan et al., 2008) our scRT-PCR data confirm that neurons
in the PVNmc (Dabrowska et al., 2011) and PVNpc do not
express GAD67 mRNA transcripts. However, we have observed
GAD67-immunoreactive neurons at high levels in the perinuclear
region adjacent to the PVN, which might be consistent with
the presence of local inhibitory interneurons reported in earlier
in situ hybridization studies of GAD67 expression in the PVN
(Cole and Sawchenko, 2002). Indeed, CRF neurons of the medial
PVNpc were shown to be targets of GABAergic inputs originating
from neurons in the perinuclear zone (Roland and Sawchenko,
1993; Boudaba et al., 1996; Miklos and Kovacs, 2002), as well as
from extrinsic sources such as the BNST (Herman and Cullinan,
1997).
The BNST is thought to be a major relay site for limbic input
into the PVN (Cullinan et al., 1993; Dong et al., 2001; Zhu et al.,
2001; Crane et al., 2003) and, notably, the PVNpc receives the
heaviest BNST projection from the oval and fusiform nuclei,
which contain the CRF neurons (Dong et al., 2001; Dong and
Swanson, 2006). Lesion studies have shown that the anterior
BNST mediates HPA axis activation, while the posterior BNST
is involved in HPA axis inhibition (Choi et al., 2007) and there-
fore it has been suggested that CRF neurons of the anterior BNST
might co-express glutamate (Silverman et al., 1989). However, we
have shown that CRF neurons of the BNSTALG do not express
mRNA transcripts for any of the three VGLUT isoforms and,
instead, express transcripts and protein for GAD67. Our results
are consistent with previous in situ hybridization studies show-
ing that the BNST is predominantly a GABAergic structure (Sun
and Cassell, 1993; Bowers et al., 1998; Day et al., 1999; Bali et al.,
2005). At first glance these results would seem to contradict the
results of the lesion studies showing activation of the HPA axis
by the anterior BNST. However, Choi and colleagues proposed
that it was the anterior BNST, ventral to the commissure, in the
region of the fusiform nucleus that was responsible for activation
of the PVN, and not the BNSTALG (Choi et al., 2007). The oval
nucleus of the BNSTALG projects heavily to the fusiform nucleus
(Dong et al., 2001) and, hence, inhibition of fusiform neurons
may functionally disinhibit the PVN.
More recently, it has been proposed that neurons in the
region of the fusiform nucleus are glutamatergic (Georges and
Aston-Jones, 2002; Jennings et al., 2013). However, there is some
question about the validity this observation as the results from
several in situ hybridization studies, including those reported in
the Allen Brain Atlas, suggest that only a few putative VGLUT2-
3 mRNA expressing neurons are present in this region (Herzog
et al., 2001; Kudo et al., 2012). Nevertheless, if CRF neurons of
the BNSTALG are involved in the acute response to stressors via an
indirect pathway then inhibition of putative glutamatergic neu-
rons in the ventral BNST would paradoxically decrease activation
of the PVN. An alternative mechanism might be that activation
of GABA/CRF neurons in the BNSTALG could indirectly activate
the HPA axis by dis-inhibiting GABAergic interneurons of the
perinuclear zone. However, no study to date has reported direct
projections from the BNSTALG to this region.
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Notably, Day and colleagues have suggested that systemic stres-
sors, such as infection, do not activate CRF neurons in the
BNSTALG, but instead activate ENK neurons (Day et al., 1999)
as measured by alterations in c-fos expression. However, Cullinan
and colleagues (Cullinan et al., 1995) have reported that psycho-
logical stressors, such as restraint stress, cause a dramatic increase
in the expression of another immediate early gene, Zif/268, but
caused only low level c-fos expression. Hence, activation of CRF
neurons on the BNSTALG may be critically dependent on the
nature of the stressor, and detection of their activation is depen-
dent on which immediate early gene is screened.
Interestingly, the majority of PVN CRF neurons also co-
expressed mRNA transcripts for OT, and some of the magno-
cellular neurons also co-expressed transcripts for the OTR. OT
is classically viewed as an anxiolytic neurotransmitter (Mccarthy
et al., 1996; Ebner et al., 2005; Lee et al., 2009) and, hence,
the potential for OT expression in parvocellular CRF neurons
is intriguing and raises the possibility that these neurons could
switch their neurochemical phenotype depending on environ-
mental demands. Dynamic regulation of neuronal phenotype
is not without precedence in the CNS. Hence, during lactation
tuberoinfundibular dopamine neurons begin to express ENK,
which prevents dopamine from inhibiting prolactin secretion
(Merchenthaler, 1993). Dynamic changes in the expression of
both CRF1 and CRF2 receptors were also reported in hypothala-
micmagnocellular neurons expressing AVP andOT in response to
hyperosmotic stress (Arima and Aguilera, 2000). It is possible that
prolonged periods of stress may dynamically regulate the neuro-
chemical phenotype of parvocellular CRF neurons in a similar
manner.
Moreover, our data showing co-expression of OT and OTR
transcripts is consistent with previous autoradiography studies
showing OTR expression in OT neurons (Adan et al., 1995), sug-
gesting that the OTR in this cell population might serve as an
autoreceptor to regulate OT release (Freund-Mercier and Richard,
1984). Interestingly, we reported previously that the majority of
CRF neurons in the BNSTALG also expressed mRNA transcripts
for the OTR (Dabrowska et al., 2011), suggesting that OT could
regulate the activity of CRF neurons in the BNSTALG and there-
fore directly modulate affective behavior. In the current study we
show that the majority of non-CRF neurons in the PVN have the
potential to produce OTR, suggesting that local OT release could
differentially modulate the excitability of the parvocellular neu-
rons, and therefore impact the activity of the HPA axis as it was
suggested before (Neumann et al., 2000). However, mRNA tran-
script expression does not necessarily translate into expression of
the mature peptide, since we have previously demonstrated rela-
tively sparse co-localization of CRF- and OT-neurons in the PVN
(Dabrowska et al., 2011).
It is noteworthy that we saw no co-expression of CRF with
AVP in either the PVN or BNSTALG, particularly considering that
CRF and AVPhave previously been reported to co-localize in both
the PVNpc and PVNmc (Ma et al., 1997; Arima et al., 2001).
Sawchenko and colleagues have reported that acute stress can
cause a delayed induction of AVP mRNA transcripts in PVNpc
CRF neurons (Kovacs and Sawchenko, 1993; Sawchenko et al.,
1993). It is possible that in our unstressed animals the expression
level of AVP transcripts is just below our detection threshold. In
addition, is has been suggested that two populations of CRF neu-
rons exist in the PVNpc, one that co-express AVP and one that
does not (Whitnall and Gainer, 1988). It is possible that with our
relatively small sample size we have unintentionally biased our
recordings for scRT-PCR toward the former population.
We have also shown that Type III CRF neurons in the BNSTALG
and PVNpc CRF neurons both express mRNA transcripts for
V1BR, but not V1AR, whereas non-CRF Type I neurons of the
BNSTALG express V1AR but not V1BR. These findings are con-
sistent with previous studies showing a high level of expression
of the V1B receptor in the PVN, where it is known to play
an key role in modulating activity of the HPA axis (Nair and
Young, 2006); for review see (Roper et al., 2011). Significantly,
V1B receptor knockout mice have been shown to have a blunted
ACTH response to both acute and repeated stress, however, this
response is critically dependent on the context of the stressor
(Lolait et al., 2007). Our results showing V1BR transcript expres-
sion in BNSTALG, as well as PVN,CRF neurons would suggest that
the effect of the receptor knockout would depend on whether or
not a particular stressor activated one or both of these pathways.
Consistent with this hypothesis recent studies with the non-
peptide V1B receptor antagonist, suggest that extra-hypothalamic
V1B receptors may play a critical role in the regulation of affect
(Salome et al., 2006). We have preliminary scRT-PCR evidence
suggesting that those Type I BNSTALG neurons that express V1AR
co-express GABA and either somatostatin or enkephalin (Hazra
and Rainnie, unpublished observations). Hence, local AVP release
might differentially regulate sub-populations of BNSTALG neu-
rons and modulate different behavioral outputs. Consistent with
this notion, previous studies have suggested a complementary or
cooperative effect of AVP receptor activation on behavioral out-
put (Ring, 2005; Veenema and Neumann, 2008). Central V1B
receptors were shown to mediate anxiety (Ishizuka et al., 2010),
while V1A receptors in the BNST were positively correlated with
maternal aggression (Bosch et al., 2010; Caughey et al., 2011). The
BNST is known tomediate both anxiety-like andmaternal aggres-
sion behavior, thus our results suggest that in the BNST, Type III
CRF neurons and Type I neurons might mediate distinct anxiety-
and aggression-related behavioral outcomes, respectively.
Finally, using in vitro patch-clamp techniques, we have demon-
strated that CRF neurons of the PVN and BNSTALG display
similar, and yet distinct basic membrane properties. Previously,
we have identified three electrophysiologically and genetically dis-
tinct cell types (Type I–III) in the BNSTALG (Hammack et al.,
2007; Hazra et al., 2011), and have further identified Type III
neurons as corresponding to the CRF containing cell population
(Martin et al., 2010; Dabrowska et al., 2011). Previous studies in
the PVN have also identified three neuronal subtypes (Type I–III)
based on their electrophysiological properties (Hoffman et al.,
1991; Tasker andDudek, 1991; Luther and Tasker, 2000), and type
I and II neurons were subsequently identified as being magnocel-
lular and parvocellular neurons, respectively (Luther and Tasker,
2000). Significantly, the parvocellular CRF neurons recorded in
our study have many electrophysiological properties similar to
those previously reported for the neurosecretory subpopulation
of type II parvocellular PVN neurons (Tasker and Dudek, 1991);
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in that PVNpc CRF neurons displayed moderate spike-frequency
adaptation of the action potential firing pattern from rest, and
had a pronounced post-spike fast AHP. However, no rebound
low-threshold burst firing activity was observed in PVNpc CRF
neurons following transient hyperpolarizing current injection.
Two distinct cell populations have been reported in the PVNpc
(Hermes et al., 1996), one of which shows robust rebound low-
threshold burst firing activity (type III) and one that does not
(type II). Consistent with this observation we observed a subpop-
ulation of non-CRF PVNpc neurons that did show low-threshold
burst firing activity. Moreover, CRF PVNpc neurons showed a
marked time-independent anomalous rectification of the volt-
age transient in response to hyperpolarizing current injection
similar to that previously reported in type II and III PVNpc
neurons.
Like the PVNpc CRF neurons, the PVNmc CRF neurons in
this study also exhibited a marked time-independent anoma-
lous rectification. However, PVNmc neurons have previously
been reported to lack this time-independent inward rectifica-
tion (Tasker and Dudek, 1991). Consistent with the previous
studies, non-CRF PVNmc cells in the current study did not
exhibit the inward rectification, indicating that the CRF PVNmc
cells exhibit electrophysiological properties more similar to that
of PVNpc neurons than other PVNmc neurons. Another dis-
tinguishing property of PVNmc, or Type I neurons, is a large
A-type K+ current (IA; Luther and Tasker, 2000). Although we
did not measure IA directly in this study, we did observe an
∼200ms delay in the onset to the first action potential in 3/4
CRF PVNmc cells compared to PVNpc neurons in response to
low intensity current injection (Figure 4B). However, due to the
small sample size of PVNmc neurons (n = 4) it is impossible to
draw any definitive conclusions about the factors mediating this
response.
Intriguingly, CRF neurons of the PVN and BNSTALG had
many overlapping physiological properties such as a regular firing
pattern, and a strong inward-rectification of the voltage response
to hyperpolarizing current injection. However, consistent with
differences observed in our immunohistochemical and transcrip-
tomic analysis, Type III CRF neurons and PVNpc CRF neurons
were significantly different in many other aspects of their mem-
brane properties. Hence, PVNpc CRF neurons had a much higher
input resistance (1180M) compared to the CRF neurons in
the BNSTALG (226M), which suggests that the same excitatory
input would cause a greater depolarization in PVNpc CRF neu-
rons. Although CRF neurons in the BNSTALG had a more hyper-
polarized threshold for action potential (−39mV) than PVNpc
CRF neurons (−33mV), PVNpc CRF neurons also showed a
more depolarized resting membrane potential (−56mV) com-
pared to BNSTALG CRF neurons (−66mV), which together with
the higher input resistance suggests that excitatory synaptic input
would be more likely to drive PVNpc CRF neurons to action
potential threshold than those in the BNSTALG. Furthermore,
previous studies have shown that PVNpc neurons exhibit a strong
IT current that contributes to a low-threshold spiking pattern and
only a little IA (Tasker andDudek, 1991; Luther and Tasker, 2000).
Although we did not observe burst firing in the current study,
we have confirmed that the parvocellular PVN neurons, which
expressed CRF, also co-expressed Cav3.1 and Cav3.2 subunits
mediating the IT currents. Conversely, the Type III putative CRF
neurons in the BNST do not exhibit low-threshold firing indica-
tive of an IT current (Hammack et al., 2007), but do show
significant IA currents (Rainnie et al., 2013). However, in the cur-
rent study we have shown that the great majority of Type III,
putative CRF neurons of the BNSTALG co-expressed Cav3.3 sub-
unit. The lack of low-threshold firing in these neurons, despite
the probable presence of voltage-gated calcium channels, is most
likely due to the opposing IA current found in these cells.
PVNpc CRF neurons are responsible for a rapid activation of
the HPA axis to initiate the endocrine response to stress stimuli
(Rivier and Vale, 1983), while the CRF neurons in the BNSTALG
are thought to modulate the affective component of the stress
response, which is most likely context-dependent and slower
(Walker et al., 2009) but see Sterrenburg et al. (2012). Thus, the
functional separation of these two neuronal populations might
be partially explained by their distinct membrane properties and
concomitant ion channel expression pattern.
In conclusion, we reported that although CRF neurons in the
PVN and the BNSTALG share the same neuropeptide phenotype,
they represent distinct neuronal populations. Hypothalamic CRF
neurons are glutamatergic (excitatory), whereas the CRF neu-
rons in the BNSTALG are GABAergic (inhibitory). Functional
separation of these two groups of CRF neurons can be further
distinguished by their distinct membrane properties, such that
hypothalamic CRF neurons are more likely to be rapidly activated
in response to stress to initiate HPA axis activation, while CRF
neurons in the BNSTALG display membrane properties which
suggest that greater stimulus is needed to reach action potential
threshold in these neurons. Consistent with this observation, CRF
neurons in the BNST are thought to modulate the affective com-
ponent of the stress response, and previous studies have suggested
that in contrast to the PVN neurons, CRF neurons in the BNST
may only be activated in response to chronic, but not acute stress
(Kim et al., 2006). Furthermore, we have shown that OT and AVP
as well as their cognate receptors co-exist in intimate relationships
with CRF neurons in both PVN and the BNSTALG. However, OT
is more likely to regulate the excitability of CRF neurons in the
BNSTALG than in the PVN, therefore OT-CRF neurotransmission
seems to be more likely involved in the affective component of the
stress response than in the classic endocrine response to stress.
In contrast, V1BR were widely expressed in both PVN and the
BNST CRF neurons, which suggests that AVP may be involved in
both HPA axis activation as well as in the affective component
of the stress response, which is mediated by CRF neurons in the
BNSTALG.
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